FDA approves Gilead's antiviral remdesivir drug for treatment of COVID-19
Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days
Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days
The partnership aims to expand existing Monocyte Distribution Width (MDW) hematology-based biomarker to potentially aid in the rapid detection of MIS-C
Easy-to-use test, which doesn't require specialized laboratory personnel or instruments, promises flexibility to test in locations that benefit from immediate results
Find out how to rapidly test for multiple disease-causing microorganisms with syndromic panel-based testing
Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions in the field
Early surgical treatment of leg ulcers caused by varicose veins improves healing and reduces the risk of the condition coming back
CE mark for MitraClip G4 offers physicians an innovative next-generation system with more options for mitral valve repair using proven clip-based technology
The Direct assay is validated on a wide range of specimen types, and can be run in parallel with the Simplexa Flu A/B & RSV Direct Gen II assay
New test expands Roche molecular test menu for transplant patients, enabling simultaneous testing of BK virus with Cytomegalovirus and Epstein-Barr virus
Test to be integrated in over 5,000 DiaSorin analyzers, allowing physicians to differentiate between bacterial and viral infections
Data shows 100% concordance with results from Dartmouth-Hitchcock’s lab-based polymerase chain reaction (PCR) test method
Rapid increase in production of VTM and saline will help boost virus testing
The new AI technology will learn from past CT scans of COVID-19 pneumonia patients, reducing the burden on doctors making diagnoses
Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions
Test delivers results in just 15 minutes with no instrumentation, using proven lateral flow technology with demonstrated sensitivity of 97.1% and specificity of 98.5%
Syndromic testing will streamline respiratory infection diagnosis as COVID-19 pandemic collides with start of flu season
The AI-Rad Companion Brain MR and Prostate MR measures volumetric changes in brain, and segments prostate for targeted biopsy under MRI and ultrasound fusion imaging respectively
The Somatom scanner is equipped with a forward-looking camera and motorized wheels, allowing a single technologist to navigate the device through hospital hallways
Access Anti-SARS-CoV-2 is an easy-to-use 10-minute test on a portable device that provides highly accurate results on total Ig antibodies